Skip to content

Weight Loss and Gastrostomy Tube Care Outcomes in Head and Neck Cancer Patients With Gastrostomy Tube Placement

Weight Loss and Gastrostomy Tube Care Outcomes in Head and Neck Cancer Patients With Gastrostomy Tube Placement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02775721
Acronym
G-Tube
Enrollment
100
Registered
2016-05-18
Start date
2015-07-31
Completion date
2018-12-31
Last updated
2018-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrostomy, Malnutrition

Keywords

Nursing Education, Weight Loss, Gastrostomy Tube Care

Brief summary

Poor nutritional status and malnutrition are prevalent for patients undergoing treatment for head and neck cancer. Inadequate dietary intake is multi factorial, with patients experiencing dysphagia and or anorexia caused by various cancer treatments. Current standard practice utilizes Gastrostomy Tube placement to manage adverse nutritional effects related to Head and Neck cancer treatment.

Detailed description

The purpose of this study is to assess the quality of life and educational intervention outcomes of Head and Neck Cancer patients who have a gastrostomy tube placed per standard of care. A high incident of Gastrostomy tube replacement occurs related to clogged, dislodged, and/or pulled out tubes. In addition, patients not eating or drinking after Gastrostomy tube placement, compounded by complications related to radiation treatment, results in decreased swallowing function. Inadequate swallow function, especially when combined with inadequate use of Gastrostomy tube, due to non-functional tube or insufficient patient knowledge in use of tube, results in poor nutritional status and excessive weight loss.

Interventions

OTHERNursing Education related to Gastrostomy Tube Care

The research nurse will provide educational intervention at each study visit utilizing the nursing process.

OTHERSpeech Therapy Education and Evaluation

Speech therapy will be conducted per standard of care, the protocol does not dictate the frequency or treatment plan of care. Speech therapy and evaluation is assessed per the attending speech therapist. The study team will collect all data related to speech therapy education and evaluation at each study visit per protocol. All collected data will be utilized in final protocol analysis.

OTHERNutritional Therapy Education and Evaluation

Nutritional therapy will be conducted per standard of care, the protocol does not dictate the frequency or treatment plan of care. Nutritional therapy and evaluation is assessed per the attending dietitian. The study team will collect all data related to nutritional therapy education and evaluation at each study visit per protocol. All collected data will be utilized in final protocol analysis.

OTHERQuality of Life Questionnaire C30 version 3

30-item instrument that measures the Health Related Quality of Life (HRQoL) in a wide range of cancer patient populations.

OTHERQuality of Life Questionnaire EORTC QLO - H&N35

35-item instrument that measures the Health Related Quality of Life specific to Head and Neck cancer patient populations.

Sponsors

St. John Health System, Oklahoma
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years and older * Head and Neck cancer diagnosis * Esophageal cancer diagnosis * Receiving chemotherapy and/or radiation therapy * Gastrostomy Tube placed within the last 30days or scheduled to have a gastrostomy tube placed within the next 30 days

Exclusion criteria

* Not eligible for chemotherapy and/or radiation therapy * Unwilling or unable to sign informed consent * Any cognitive or mental deficits that would prevent patient from completing questionnaires or understanding educational interventions * Current pre-existing Gastrostomy tube complications if a current Gastrostomy tube is in place prior to informed consent (i.e., skin breakdown, tube breakdown, other tube complications). * No Gastrostomy tube placement * Non-English Speaking

Design outcomes

Primary

MeasureTime frameDescription
Sustained ± 10% body weight post gastrostomy tube placement for cancer therapy treatment.through study completion, an average of 2 yearsPatient Reported Outcomes utilizing EORTC QLQ-C30 version 3 and EORTC QLO - H&N35 Questionnaires.
Patient loss of speech increase or decreasethrough study completion, an average of 2 yearsMeasure functional status of speech therapy every 30 days
Patient loss of swallow function increase or decreasethrough study completion, an average of 2 yearsEORTC QLO - H&N35 Questionnaire

Secondary

MeasureTime frameDescription
Patient knowledge of management and care of Gastrostomy Tube.through study completion, an average of 2 yearsNursing Education utilizing the Gastrostomy Tube education booklet will improve patient's knowledge and management of Gastrostomy Tube care
Patient Reported Outcomes utilizing EORTC QLO - H&N35 Questionnaire.through study completion, an average of 2 yearsAssess Quality of Life
Maintaining swallowing functionthrough study completion, an average of 2 yearsSpeech therapy
Patient Reported Outcomes utilizing EORTC QLQ-C30 version 3 Questionnaire.through study completion, an average of 2 yearsAssess Quality of Life

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026